AsthenopiaNCT06418191
Mobile Apps Enhancing Acupressure Therapy Compliance and Efficacy for Asthenopia
A study testing Acupressure in people with Asthenopia, run by Universitas Indonesia at 1 site in Indonesia.
Trial summary
The goal of this clinical trial is to learn if a mobile application works to improve adherence to acupressure therapy in asthenopia. It will also learn about the efficacy of acupressure as a therapy for asthenopia. Read more about this study
- Who is it for?
- Ages 18 to 64 yearsHealthy volunteers can take part
- Conditions the study is for
- Asthenopia
- What is being tested?
- Acupressure
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 57 participants
- Where
- 1 siteIndonesia
- Study dates
- 1 Jun 2024to 1 Sep 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 64 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Using a smartphone with the Android platform.
- Work or use digital gadgets for at least 4 hours a day.
- Suffering from asthenopia as indicated by a CVS-Q score ≥ 6.
- Can be contacted with the WhatsApp application.
- Willing to take part in this research until completion and agree to informed consent.
Who cannot join
- There are tumors, wounds or skin infections in the eye area.
Trial locations and contacts
1 site in 1 country.
Indonesia1 site
Cipto Mangunkusumo Hospital
Jakarta Pusat, DKI Jakarta, 10430
About this study
Official title: The Role Of Mobile Applications In Therapy Compliance And Efficacy Of Acupressure In Asthenopia
The goal of this clinical trial is to learn if a mobile application works to improve adherence to acupressure therapy in asthenopia. It will also learn about the efficacy of acupressure as a therapy for asthenopia. The main questions it aims to answer are:
-Does a mobile application have a role to improve therapy compliance and efficacy of self-guided acupressure in asthenopia?
Read more
Researchers will compare users of a mobile app to non-users of a mobile app to see if a mobile app works to improve adherence to acupressure therapy in asthenopia
Participants will:
- Do acupressure 2 times every day for 4 weeks
- Filling in the absence link has been after doing acupressure every day
- Fill out the link regarding the condition of asthenopia once per week
Read the detailed description
This is a clinical trial study to evaluate the role of a mobile application in therapy compliance and acupressure efficacy in asthenopia sufferers. Participants are 60 males/females aged 18-64 years. They will be divided into 2 groups: (1) Acupressure mobile app users and (2) Non-acupressure mobile app users. Acupressure is scheduled 2 times every day for 4 weeks. Therapy compliance will be assessed from the absence link that participants fill out every day, while therapy efficacy will be assessed once per week for 4 weeks.
- Conditions
- Asthenopia
- Being tested
- Acupressure
- Medical subject headings
- Asthenopia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
AcupressureProcedure or surgery
Acupressure is a technique that involves applying pressure to specific points on the body. It is based on the same principles as acupuncture but uses pressure from fingers, palms, elbows, or specialized devices instead of needles.
| Study group | Role | What they receive |
|---|---|---|
| Mobile app users | Experimental | Mobile application users will be notified twice per day to perform acupressure. Instructions for performing acupressure are in the mobile app Receives: Procedure: Acupressure |
| Not a mobile app user | Active comparator | Non-users of the mobile application will be given an explanation of how to perform acupressure at the start of the study and will not be reminded to perform acupressure therapy. Receives: Procedure: Acupressure |
What is being measured
The primary outcome is the main question the study is designed to answer.
Daily Report of Acupressure
Daily acupressure reports are used to monitor participants' therapeutic compliance in performing acupressure every day
Measured: 2 times every day for 4 weeks
Secondary outcomes (2)
Computer Vision Syndrome Questionnaire (CVS-Q)
The Computer Vision Syndrome Questionnaire (CVS-Q) is a tool used to assess symptoms related to prolonged computer use or other digital screens. It typically consists of a series of questions designed to evaluate various discomforts experienced by individuals who spend significant time in front of screens. These questions may inquire about symptoms such as eye strain, headaches, blurred vision, dry eyes, neck or shoulder pain, and general fatigue.
A CVS-Q score ≥ 6 indicates asthenopia
Measured: Monitored once per week for 4 weeks
Visual Analog Scale (VAS)
VAS is used to assess complaints of asthenopia intensity on a scale of 1-10
Measured: Monitored once per week for 4 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 May 2024
- Study start1 Jun 2024
- Primary completion1 Aug 2024
- Study completion1 Sep 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for AsthenopiaStudies of the same condition, open and under way.
- More trials run by Universitas IndonesiaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 57 participants (actual)
Sponsor and investigators
- Lead sponsor
- Universitas Indonesia
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Dion Rukmindar, Universitas Indonesia
- Investigators
- KEPK FKUI-RSCM, Principal investigator, The Ethics Committee of the Faculty of Medicine, University of Indonesia - RSCM
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06418191
- Sponsor's protocol ID
- 24-03-0424
- Status last verified
- Mar 2025
- First submitted
- 12 May 2024
- Last updated
- 4 Mar 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 4 Mar 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Role Of Mobile Applications In Therapy Compliance And Efficacy Of Acupressure In Asthenopia
- ClinicalTrials.gov ID
- NCT06418191
- Acronym / sponsor ID
- 24-03-0424
- Conditions
- Asthenopia
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 57 participants (actual)
- Lead sponsor
- Universitas IndonesiaUniversity, hospital or other
- Study start
- 1 Jun 2024 (actual)
- Primary completion
- 1 Aug 2024 (actual)
- Study completion
- 1 Sep 2024 (actual)
- First posted
- 17 May 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to learn if a mobile application works to improve adherence to acupressure therapy in asthenopia. It will also learn about the efficacy of acupressure as a therapy for asthenopia. The main questions it aims to answer are:
-Does a mobile application have a role to improve therapy compliance and efficacy of self-guided acupressure in asthenopia?
Researchers will compare users of a mobile app to non-users of a mobile app to see if a mobile app works to improve adherence to acupressure therapy in asthenopia
Participants will:
- Do acupressure 2 times every day for 4 weeks
- Filling in the absence link has been after doing acupressure every day
- Fill out the link regarding the condition of asthenopia once per week
Detailed description
This is a clinical trial study to evaluate the role of a mobile application in therapy compliance and acupressure efficacy in asthenopia sufferers. Participants are 60 males/females aged 18-64 years. They will be divided into 2 groups: (1) Acupressure mobile app users and (2) Non-acupressure mobile app users. Acupressure is scheduled 2 times every day for 4 weeks. Therapy compliance will be assessed from the absence link that participants fill out every day, while therapy efficacy will be assessed once per week for 4 weeks.
Study design
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Mobile app users | Experimental | Procedure: AcupressureMobile application users will be notified twice per day to perform acupressure. Instructions for performing acupressure are in the mobile app |
| Not a mobile app user | Active comparator | Procedure: AcupressureNon-users of the mobile application will be given an explanation of how to perform acupressure at the start of the study and will not be reminded to perform acupressure therapy. |
Who may qualify
- Ages
- 18 to 64 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (5 listed)
- Using a smartphone with the Android platform.
- Work or use digital gadgets for at least 4 hours a day.
- Suffering from asthenopia as indicated by a CVS-Q score ≥ 6.
- Can be contacted with the WhatsApp application.
- Willing to take part in this research until completion and agree to informed consent.
Key exclusion criteria (1 listed)
- There are tumors, wounds or skin infections in the eye area.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| AcupressureAcupressure is a technique that involves applying pressure to specific points on the body. It is based on the same principles as acupuncture but uses pressure from fingers, palms, elbows, or specialized devices instead of needles. | Procedure or surgery | Mobile app users, Not a mobile app user |
Primary outcome
Daily Report of Acupressure
Time frame: 2 times every day for 4 weeks
Daily acupressure reports are used to monitor participants' therapeutic compliance in performing acupressure every day
2 secondary outcomes
Computer Vision Syndrome Questionnaire (CVS-Q)
Time frame: Monitored once per week for 4 weeks
Visual Analog Scale (VAS)
Time frame: Monitored once per week for 4 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Mar 2025.
- Individual participant dataSharing planned: No
Related trials for Asthenopia
Recruiting
Lactic Acid Bacteria for Reducing Blue Light-Induced Eye Fatigue
Digital Eye Strain (DES)
Not yet recruiting
Comparative Effects of Exercises on Pain, Cervical Proprioception, Neck Disability and Visual Performance in Patients With Computer Vision Syndrome.
Computer Vision Syndrome
Not yet recruiting
Study of Eye Fatigue From Digital Screens and Its Impact on Visual Performance in People With Normal Vision and Myopia, With and Without Dry Eye Symptoms and Signs
Myopia, Dry Eye Disease (DED)
Not yet recruiting
A Study of Full-Spectrum Screen Lighting for Reducing Screen-Related Eye Fatigue and Dry Eye
Visual Fatigue, Dry Eye
Not yet recruitingObservational study
Exploration Strategies in Night Vision Sensors
Visual Acuity
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
KEPK FKUI-RSCM principal investigator
The Ethics Committee of the Faculty of Medicine, University of Indonesia - RSCM
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Acupressure in people with Asthenopia, run by Universitas Indonesia at 1 site in Indonesia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 4 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Indonesia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Daily Report of Acupressure (time frame: 2 times every day for 4 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Mar 2025.